Table 2.
Potential therapies targeting CFH-mediated endothelial injury
| Therapy | Method of Action | References |
|---|---|---|
| Haptoglobin | Endogenous scavenger of hemoglobin | (17, 21, 27, 66, 80, 82, 84–86, 88, 90) |
| Hemopexin | Endogenous scavenger of heme | (22, 80, 82, 84, 89, 90) |
| Plasma proteins (e.g. albumin) | Binds hemoglobin/heme | (69, 93) |
| Acetaminophen | Hemoprotein reductant | NCT04291508 (21, 25, 91, 92) |
| Ascorbate | Antioxidant | (34, 89) |
| NO donors [nitrite, nitrate, spermine NONOate (SPNO), S-nitrosoglutathione (GSNO)] | Delivers NO (increases bioavailability in hypoxic areas and reduces hemolysis) | (24, 94, 95) |
| Febuxostat | Xanthine oxidase inhibitor | (96) |